Presentation SCAI 2018 The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock Presenter: Andrew McNeice April 28, 2018 REGISTER for free or LOG IN to view this content Coronary ACS/AMI Presentation SCAI 2018 Cardiogenic Shock Up Next Presentation SCAI 2018 Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement Presenter: Sahil Khera April 28, 2018 More slides + Presentation EAS 2018 LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis Presenter: Brian A. Ference May 07, 2018 Presentation EAS 2018 Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial Presenter: Michelle L. O’Donoghue May 07, 2018 We Recommend
Presentation SCAI 2018 Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement Presenter: Sahil Khera April 28, 2018
Presentation EAS 2018 LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis Presenter: Brian A. Ference May 07, 2018
Presentation EAS 2018 Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial Presenter: Michelle L. O’Donoghue May 07, 2018